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Antimicrobial usage and in particular, antibiotic usage in farmed, food producing species has become 
the subject of increasing interest and concern over recent years. Regulatory authorities, human 
medical practitioners, veterinary surgeons, farmers, the general public and others all have a 
legitimate interest in this area but priorities and perspectives can differ widely.  
Public health and the maintenance of antibiotic efficacy in human medicine is generally accepted to 
be the principal priority for society. Addressing all possible causes and sites of antibiotic or 
antimicrobial resistance (AMR) selection should be informed by an evidence based, risk assessment 
of the most significant sources of AMR selection. Unfortunately there are huge gaps in our 
knowledge which presents problems when developing effective critical control points. For example 
misuse of antibiotics in human medicine has been estimated at 38% (Kardas et al 2005) and 
antibiotic contamination of the environment from manufacturing plants have been associated with 
an abundance of related resistance genes (Rutgersson et al 2014).  Placing veterinary use of 
antibiotics in perspective with these other areas of usage is important when making policy decisions 
especially as there are potentially competing ethical and economic pressures such as animal welfare 
to consider. 
From this starting point it is logical for each area of society to address those potential AMR risks 
which are most directly under their control. The veterinary profession has an important role to play 
in prescribing antibiotics responsibly and in communicating with farmers and owners to minimise 
the potential risk that is under our control. This is not a simple task and it is one that requires us to 
reappraise some commonly held assumptions. In this context the paper by Serrano-Rodríguez et al, 
raises some very interesting issues relating specifically to Fluoroquinolones but also more broadly to 
other antibiotics and antimicrobials.  
In 2013 Fluoroquinolones were classified along with macrolides and 3rd& 4th generation 
cephalosporins as those antibiotics on the World Health Organisation ‘Critically Important 
Antimicrobials for Human Medicine’ list which required the most urgent action to reduce the risk 
from antimicrobial resistance selection. This is of particular importance as all three of these 
antibiotic groups are in common veterinary use and hence there is interest in establishing relative 
risk for resistance selection when using these products. Serrano-Rodríguez et al, compared several 
related fluoroquinolone antibiotics to compare their pharmacological properties which relate to the 
risk of developing resistance. This study used samples collected from dairy sheep and goats. In 
various countries different fluoroquinolones are licenced for the treatment of clinical mastitis in 
sheep and cattle. The paper provides a useful insight into the relative risk of theses related active 
ingredients which may help more rational decisions to be made on appropriate treatment protocols 
and licencing provisions in the future. However, if an animal does require an antibiotic it is logical to 
avoid, as far as possible, the critically important groups in favour of those less frequently relied upon 
in human medicine in order to abide by the precautionary principal.  
Furthermore, there is a far larger and wider context to be considered. The question of “which 
antibiotic we should prescribe?” should be proceeded by at least two more fundamental questions:  
1. Should we treat with antibiotics?  
2. How do we prevent new clinical cases?  
The answer to the first question touches on a number of important priorities that apply to the use of 
antibiotics in many farm animal veterinary situations when the alternative to antibiotic treatment 
may be;  poor animal welfare, poor milk yield, reduced productivity and/or reduced efficiency.  
In the case of dairy sheep and goat production attitudes and practices vary greatly across Europe 
and may reflect differences in veterinary and farming culture or expectations as much as licencing of 
available products. For example, in the UK the dry-off and culling of acute and chronic mastitis cases 
in sheep, rather than treatment of cases and retention in the milking flock, is standard practice for 
many dairy flocks. This approach is arguably more logical in any event given the low cure rates (39-
82%, Attili et al, 2016) and long term negative impact yield and milk quality (SCC) of 
subclinical/chronic mastitis, along with the relatively low ewe replacement costs.  
To answer the second question it is important for the clinician to consider not just what is the most 
appropriate approach or treatment for the individual ewe but to address the issue as a matter of 
preventive population health to reduce the clinical need to consider using antibiotics. This is 
fundamental and applicable to all areas of food animal production.  
The prudent use of antimicrobials to treat disease in food producing species brings benefits in terms 
of animal welfare and productively but can only be justified when all other reasonable measures 
have been taken to reduce the disease prevalence. We must also refine our prescribing decisions to 
avoid unnecessary selection for AMR that could be detrimental to both animal and human health. 
The prescribing veterinary surgeon is the critical person in this context, who must exercise their 
informed, professional judgment to balance their responsibilities too their patient, client and the 
wider society.  
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